http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103784727-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8968 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8968 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103784727-B |
| titleOfInvention | Folium mori compound preparation and application thereof |
| abstract | The invention discloses a traditional Chinese medicinal composition, a compound preparation and an application thereof. The traditional Chinese medicinal composition comprises the following components in parts by weight: 10-300 parts of Morus alba leaf extract, 10-300 parts of bitter gourd extract, 10-300 parts of Astragalus membranaceus extract and 10-300 parts of Ophiopogon japonicus. The compound preparation product prepared from the traditional Chinese medicinal composition is prepared from natural plant extracts, has stable quality, no toxic and side effects, convenience in administration, smooth action, definite therapeutic effect, stable dosage form, and controllable quality, and can meet the requirements of patients at prediabetic stage and type II diabetics. |
| priorityDate | 2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.